The Cigna (CI) Q2 2026 earnings — TrendMatrix coverage
Reported
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Full disclosure
Key numbers
- Reported EPS
- $7.78
- Estimate
- $7.60
- Surprise
- +2.4%
- Revenue (period 2026-06-30)
- $71.67B
- Score at report (before → after)
- 5.7 → 5.7/10
Revenue source: xbrl.
How the report landed
The Cigna (CI) beat the $7.60 estimate with diluted EPS of $7.78 — a modest 2.4% upside surprise. TrendMatrix's engine moved from Data Issue (5.7/10) to Buy (Wait) at 5.7/10 after the report.
Where TrendMatrix's rating stands now
TrendMatrix currently rates CI Hold at 5.6/10.
4 of the last 4 quarters beat the estimate; this quarter's +2.4% surprise compares with a +2.4% four-quarter average. Next scheduled report: 2026-11-05.
What supports the rating
- Sector modifier (Healthcare): +0.5
- Strong earnings beat streak (4/4)
What argues against it
- Thin upside margin: 7.3%
- V7 low-quality RISK_OFF penalty: -0.5 (Q=4.1)
- Earnings estimates trending DOWN
This section and the ones below it reflect TrendMatrix’s latest engine read — they update after the report date and are not frozen to it.
The levels TrendMatrix's engine tracks
- Current price
- $286.26
- Price target
- $307.27
- Stop
- $275.16
- Upside to target
- +7.3%
- Reward-to-risk
- 1.4:1
The stock trades at 11.7× trailing but 8.5× forward earnings — consensus estimates already build in a substantial earnings recovery.
Model outputs from TrendMatrix’s engine as of 2026-09-04 — shown for context, not personalized investment advice.
CI at TrendMatrix's latest read
Healthcare earnings trade on pipeline and payer dynamics as much as the quarter itself; a beat or miss is weighed against trial and reimbursement news.
- Industry
- Healthcare Plans
- Market cap
- $75.64B
- P/E (fwd)
- 8.5
- P/E (ttm)
- 11.7
- 52-week range
- $239.51–$315.47
- Off 52-week high
- 9.3%
- RSI (14)
- 55
- Volume vs avg
- 1.15×
- Score today
- 5.6/10